Literature DB >> 17600725

Endocrine manifestations in Langerhans cell histiocytosis.

Polyzois Makras1, Krystallenia I Alexandraki, George P Chrousos, Ashley B Grossman, Gregory A Kaltsas.   

Abstract

Langerhans cell histiocytosis is a rare, multisystem disease that shows a particular predilection for hypothalamo-pituitary axis involvement. Diabetes insipidus is the most frequent permanent consequence of Langerhans cell histiocytosis, developing in around a quarter of patients. Although the exact prevalence of anterior pituitary hormone deficiencies is not known, it is probably high and is almost always associated with diabetes insipidus. Established pituitary hormone deficiencies are mostly permanent and require prompt diagnosis and treatment, whereas continuous follow-up is needed to detect deficiencies that might evolve later during the course of the disease. Involvement of endocrine tissues other than the pituitary has also been described but is relatively rare. Further studies are needed to evaluate the effect that endocrine deficiencies exert on the overall prognosis of patients with Langerhans cell histiocytosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17600725     DOI: 10.1016/j.tem.2007.06.003

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  23 in total

1.  Distinctive growth pattern in a patient with a delayed diagnosis of Langerhans' cell histiocytosis.

Authors:  Athanasios D Anastasilakis; Gregory A Kaltsas; Georgios Delimpasis; Ludwig Wilkens; George Kanakis; Polyzois Makras
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

2.  Endocrine manifestations of Langerhans cell histiocytosis diagnosed in adults.

Authors:  M S García Gallo; M P Martínez; M S Abalovich; S Gutiérrez; M A Guitelman
Journal:  Pituitary       Date:  2010-12       Impact factor: 4.107

3.  Langerhans cell histiocytosis and pituitary function.

Authors:  Polyzois Makras; Gregory Kaltsas
Journal:  Endocrine       Date:  2015-01-01       Impact factor: 3.633

4.  How I treat Langerhans cell histiocytosis.

Authors:  Carl E Allen; Stephan Ladisch; Kenneth L McClain
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

5.  A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening.

Authors:  Nicholas A Tritos; Thomas N Byrne; Chin-Lee Wu; Anne Klibanski
Journal:  Nat Rev Endocrinol       Date:  2010-11-23       Impact factor: 43.330

6.  Langerhans cell histiocytosis in adolescent patients: a single-centre retrospective study.

Authors:  Hua-Cong Cai; Jia Chen; Ting Liu; Hao Cai; Ming-Hui Duan; Jian Li; Dao-Bin Zhou; Xin-Xin Cao
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

7.  The pituitary gland in patients with Langerhans cell histiocytosis: a clinical and radiological evaluation.

Authors:  Neslihan Kurtulmus; Meral Mert; Refik Tanakol; Sema Yarman
Journal:  Endocrine       Date:  2014-09-11       Impact factor: 3.633

Review 8.  Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net.

Authors:  Michael Girschikofsky; Maurizio Arico; Diego Castillo; Anthony Chu; Claus Doberauer; Joachim Fichter; Julien Haroche; Gregory A Kaltsas; Polyzois Makras; Angelo V Marzano; Mathilde de Menthon; Oliver Micke; Emanuela Passoni; Heinrich M Seegenschmiedt; Abdellatif Tazi; Kenneth L McClain
Journal:  Orphanet J Rare Dis       Date:  2013-05-14       Impact factor: 4.123

9.  Diabetes insipidus, a pituitary stalk lesion and fluorodeoxyglucose-positron emission tomography scanning.

Authors:  K Laycock; S Jain; Wm Drake; Ka Metcalfe
Journal:  JRSM Short Rep       Date:  2013-02-12

10.  Adult multisystem langerhans cell histiocytosis presenting with central diabetes insipidus successfully treated with chemotherapy.

Authors:  Jung-Eun Choi; Hae Ri Lee; Jung Hun Ohn; Min Kyong Moon; Juri Park; Seong Jin Lee; Moon-Gi Choi; Hyung Joon Yoo; Jung Han Kim; Eun-Gyoung Hong
Journal:  Endocrinol Metab (Seoul)       Date:  2014-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.